by 
Osteoporosis is a progressive skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk. The disease has a significant impact on public health worldwide and represents a major medical challenge for healthcare providers and payers. Current osteoporosis therapies are classified as antiresorptive drugs, which inhibit bone resorption, and anabolic drugs, which stimulate new bone formation. Biologics are emerging treatment options for osteoporosis and tend to have a higher efficacy compared to small molecule medicines.
The global Osteoporosis Treatment Market is estimated to be valued at US$ 14.01 billion in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The Osteoporosis Treatment Market is expected to be flourished by growing geriatric population globally. As per estimates, by 2050, 16% of the world’s population will be over 65 years of age. The rising elderly population is expected to drive the osteoporosis treatment market as the risk of osteoporosis increases with age. Additionally, surge in healthcare expenditure in developing countries also supports market growth. However, side effects associated with osteoporosis therapeutics and presence of alternative treatment options can hamper market growth over the forecast period. Still, development of novel biologics with improved efficacy and safety is anticipated to create lucrative opportunities for market players.
Segment Analysis
The global osteoporosis treatment market is segmented based on drug class, route of administration, distribution channel, and geography. Among drug class, the bisphosphonates segment dominates the market due to its high efficacy and extensive usage in prevention and treatment of osteoporosis. These drugs minimize calcium loss from bones, thereby increasing bone mineral density and reducing the risk of fractures.
PEST Analysis
Political: Governments across countries are supporting initiatives to increase awareness about osteoporosis through healthcare campaigns and programs. Various regulations have been established regarding minimum standards for diagnosis and treatment.
Economic: Rising geriatric population along with growing per capita healthcare expenditure is driving the market growth. However, patent expirations of blockbuster drugs may hinder the market to some extent.
Social: Increasing incidence of osteoporosis due to sedentary lifestyles and growing awareness about preventive healthcare are supporting the market growth.
Technological: Advancements in diagnostic technologies like CT scans and MRIs have improved detection of osteoporosis. Introduction of novel anabolic agents and monoclonal antibodies offers new treatment options.
Key Takeaways
The global osteoporosis treatment market is expected to witness high growth due to the rising geriatric population globally which is the primary demographic affected by osteoporosis. As per estimates, around 200 million people worldwide suffer from osteoporosis.
Regional analysis: North America dominates the global market owing to developed healthcare infrastructure, rapid uptake of novel drugs, and presence of key players in the region. Europe also holds a significant share due to growing awareness towards osteoporosis. Asia Pacific is expected to showcase highest growth over the forecast period driven by developing healthcare infrastructure in China and India along with increasing patient pool.
Key players operating in the osteoporosis treatment market are Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY, LIMITED, Amgen Inc., Dr. Reddy’s Laboratories Ltd., Viatris Inc., Ligand Pharmaceuticals Incorporated, Eli Lilly and Company, Asahi Kasei Corporation, F. Hoffmann-La Roche Ltd, EffRx Pharmaceuticals SA, Novartis AG, Merck & Co., Inc., GSK plc., and Pfizer Inc. Key players are focusing on new product launches, joint ventures, acquisitions, and geographic expansions to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
